Comprehensive Gastrointestinal Cancer Center
Gastrointestinal Cancer Clinical Trials
The UC Cancer Institute participates in national cooperative group trials sponsored by the National Cancer Institute (NCI), select industry sponsored studies to test promising new head and neck cancer therapies and UC investigator-initiated clinical research studies.
- To browse gastrointestinal cancer (i.e. colorectal, pancreas, liver, stomach, appendix and other GI tract cancers) clinical research studies currently open to enrollment, click here or call the UC Cancer Institute Clinical Trials Office at 513-584-7698 for more information.
Patients who have not responded to standard treatment options may qualify to participate in experimental treatment options only available through phase I “first-in-human” clinical research studies. The UC Cancer Institute is the only organization within a 100-mile radius of Cincinnati to offer a comprehensive phase I clinical trial program.
Phase I studies are the first step in testing an investigational drug in humans. The purpose of a phase I study is to find the safest way to give a new drug (for example, by mouth, IV infusion or injection) and the most effective dosage.
- To learn more about the Early Stage Drug Development/Phase I Clinical Trials Program, click here.